Table 1.
Cumulative reduction in cases (percent) of HPV 6/11/16/18 disease by HPV vaccination over time in Estonia, model estimates
| Over 25 years | Over 50 years | Over 100 years | |
|---|---|---|---|
| HPV16/18-related cervical cancer |
31 (2%) |
654 (17%) |
4103 (52%) |
| HPV16/18-related CIN2/3 |
1390 (12%) |
9541 (40%) |
32508 (68%) |
| HPV16/18-related CIN1 |
554 (15%) |
3391 (45%) |
10760 (71%) |
| HPV6/11-related CIN1 |
271 (32%) |
1016 (61%) |
2591 (77%) |
| HPV6/11-related genital warts (female) |
6663 (36%) |
23246 (63%) |
58035 (79%) |
| HPV6/11-related genital warts (male) | 2092 (28%) | 7873 (53%) | 20047 (67%) |
* Percentages rounded to nearest 1; ** Cases rounded to nearest 1.